Predictive Oncology Inc.

Equities

POAI

US74039M3097

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 21:00:00 16/07/2024 BST			5-day change	1st Jan Change
1.14 ^USD	+2.70%		+10.68%	-65.35%

06-11	Predictive Oncology Inc. Develops Novel Stem Cell Expression System for the Production of Functional and Stable G-Protein Coupled Receptors	CI
06-04	Predictive Oncology Inc. Launches Novel 3D Cell Technology to Accelerate Cancer Therapeutic Drug Discovery	CI

Predictive Oncology Inc. Announces Retirement of Thomas McGoldrick as Member of the Board of Directors

January 24, 2020 at 01:32 pm

On January 21, 2020, Thomas McGoldrick, the Chairman and a member of the Board of Directors (the "Board") of Predictive Oncology Inc. advised the Company that he intends to retire as a member of the Board effective on January 23, 2020.

Latest news about Predictive Oncology Inc.

Predictive Oncology Inc. Develops Novel Stem Cell Expression System for the Production of Functional and Stable G-Protein Coupled Receptors	06-11	CI
Predictive Oncology Inc. Launches Novel 3D Cell Technology to Accelerate Cancer Therapeutic Drug Discovery	06-04	CI
Top Premarket Gainers	05-28	MT
Predictive Oncology Inc. Announces Positive Results from Ovarian Cancer Study with UPMC Magee-Womens Hospital to be Presented at the 2024 American Society of Clinical Oncology Annual Meeting	05-28	CI
Transcript : Predictive Oncology Inc., Q1 2024 Earnings Call, May 15, 2024	05-15
Earnings Flash (POAI) PREDICTIVE ONCOLOGY Posts Q1 Revenue $419,646	05-15	MT
Predictive Oncology Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-14	CI
Wall Street Set to Open Lower Ahead of Fed Rate Decision; Private Employment Figures Top Forecasts	05-01	MT
Investors Await Fed Rate Decision as US Futures Trend Lower in Wednesday's Premarket	05-01	MT
Top Premarket Gainers	05-01	MT
Predictive Oncology Inc. Announces Significant Progress with FluGen in Development of Intranasal Flu Vaccine	04-30	CI
FUJIFILM Wako Chemicals U.S.A. Corporation and Predictive Oncology Announce Collaboration to Reduce Protein Interference in Bacterial Endotoxin Detection Testing of Biopharmaceuticals	04-25	CI
Transcript : Predictive Oncology Inc., Q4 2023 Earnings Call, Apr 01, 2024	04-01
Predictive Oncology Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-28	CI
Predictive Oncology Inc. Announces Resignation of Pamela Bush, as Chief Business Officer, Effective from February 15, 2024	02-08	CI
Transcript : Predictive Oncology Inc., Q3 2023 Earnings Call, Nov 14, 2023	11-14
Earnings Flash (POAI) PREDICTIVE ONCOLOGY Posts Q3 Revenue $715,056	11-14	MT
Predictive Oncology Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-13	CI
Predictive Oncology Inc. Announces Chief Financial Officer Changes	17/08/23	CI
Predictive Oncology Inc. Announces Executive Changes	17/08/23	CI
Transcript : Predictive Oncology Inc., Q2 2023 Earnings Call, Aug 10, 2023	10/08/23
Earnings Flash (POAI) PREDICTIVE ONCOLOGY Posts Q2 Revenue $490,110	10/08/23	MT
Predictive Oncology Inc. Reports Impairment Charges for the Second Quarter Ended June 30, 2023	10/08/23	CI
Predictive Oncology Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10/08/23	CI
Predictive Oncology Relocates Corporate Headquarters to Pittsburgh Facility	18/07/23	MT

Chart Predictive Oncology Inc.

Duration

Period

More charts

Company Profile

Predictive Oncology Inc. is a knowledge-driven company focused on applying artificial intelligence (AI) to support the development of cancer therapies. The Company operates through three segments: Pittsburgh, Birmingham, and Eagan. Pittsburgh segment provides services, which include the application of artificial intelligence (AI) using its proprietary biobank of 150,000 plus tumor samples. Pittsburgh segment also develops tumor-specific in vitro models for oncology drug discovery and research. Birmingham segment focuses on contract services and research for biopharmaceutical company clients and academic collaborators, focused on solubility improvements, stability studies, and protein production. Specifically, Birmingham provides optimized formulations for vaccines, antibodies, and other protein therapeutics. Eagan segment produces the STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal.

Sector

Medical Equipment, Supplies & Distribution

Calendar

07/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
PREDICTIVE ONCOLOGY INC.	-65.35%	4.68M
ABBOTT LABORATORIES	-6.68%	179B
MEDTRONIC PLC	-5.20%	100B
BECTON, DICKINSON AND COMPANY	-5.38%	66.67B
HOYA CORPORATION	+18.16%	44.81B
DEXCOM, INC.	-6.47%	46.16B
CENCORA, INC.	+9.74%	44.38B
METTLER-TOLEDO INTERNATIONAL, INC.	+14.01%	29.53B
TERUMO CORPORATION	+22.31%	25.83B
WEST PHARMACEUTICAL SERVICES, INC.	-6.53%	23.97B

Other Medical Equipment, Supplies & Distribution